Milton J Wallace - Net Worth and Insider Trading
Milton J Wallace Net Worth
The estimated net worth of Milton J Wallace is at least $8 Million dollars as of 2024-04-25. Milton J Wallace is the Director of Catalyst Pharmaceuticals Inc and owns about 539,184 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $8 Million. Details can be seen in Milton J Wallace's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Milton J Wallace has not made any transactions after 2012-05-29 and currently still holds the listed stock(s).
Transaction Summary of Milton J Wallace
Milton J Wallace Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Milton J Wallace owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of Milton J Wallace’s form 4 insider trades.
Insider Ownership Summary of Milton J Wallace
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CPRX | Catalyst Pharmaceuticals Inc | 2012-05-29 | director |
Milton J Wallace Latest Holdings Summary
Milton J Wallace currently owns a total of 1 stock. Milton J Wallace owns 539,184 shares of Catalyst Pharmaceuticals Inc (CPRX) as of May 29, 2012, with a value of $8 Million.
Latest Holdings of Milton J Wallace
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CPRX | Catalyst Pharmaceuticals Inc | 2012-05-29 | 539,184 | 14.63 | 7,888,262 |
Holding Weightings of Milton J Wallace
Milton J Wallace Form 4 Trading Tracker
According to the SEC Form 4 filings, Milton J Wallace has made a total of 0 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years. The most-recent trade in Catalyst Pharmaceuticals Inc is the acquisition of 11,100 shares on May 29, 2012, which cost Milton J Wallace around $6,327.
Insider Trading History of Milton J Wallace
- 1
Milton J Wallace Trading Performance
GuruFocus tracks the stock performance after each of Milton J Wallace's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Milton J Wallace is 75.31%. GuruFocus also compares Milton J Wallace's trading performance to market benchmark return within the same time period. The performance of stocks bought by Milton J Wallace within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Milton J Wallace's insider trading performs compared to the benchmark.
Performance of Milton J Wallace
Average Return
35.36%
Outperforming Transactions
80%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -13.52 | 75.31 | 8.07 | 35.36 | 43.04 | 25.93 |
Relative Return to S&P 500(%) | -15.17 | 70.72 | 0.99 | 16.02 | 27.48 | 12.82 |
Milton J Wallace Ownership Network
Ownership Network List of Milton J Wallace
Ownership Network Relation of Milton J Wallace
Milton J Wallace Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Milton J Wallace is the director of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Compliance/Legal Officer Brian Elsbernd , Chief Accounting Officer Alicia Grande , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Milton J Wallace made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 430,000 shares made by Alicia Grande , a net sale of 105,000 shares made by David S Tierney , and a net sale of 89,666 shares made by Brian Elsbernd .
In summary, during the past 3 months, insiders sold 50,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 1,804,523 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,804,523 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Milton J Wallace Mailing Address
Above is the net worth, insider trading, and ownership report for Milton J Wallace. You might contact Milton J Wallace via mailing address: 1200 Brickell Ave, Suite 1720, Miami Fl 33131.